SIMBRINZA 10mg/2mg/ml ophthalmic drops suspension EUROPHARM ORIGINAL MEDICINE
Chemical substance: brinzolamide + brimonidine
ATC code: S01EC54 • Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors
Active substance
Results for the substance brinzolamide+brimonidine
1 result
About this active substance
The combination of brinzolamide and brimonidine is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide is a carbonic anhydrase inhibitor that decreases the production of intraocular fluid, while brimonidine is an alpha-adrenergic receptor agonist that lowers pressure by reducing fluid production and increasing drainage.
The medication is administered as eye drops, usually twice daily, as directed by a doctor. It is essential for patients to follow the treatment regimen to prevent vision deterioration.
Common side effects include a burning or stinging sensation in the eyes, dry eyes, headache, and fatigue. In rare cases, allergic reactions or breathing difficulties may occur.
This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.
The medication is administered as eye drops, usually twice daily, as directed by a doctor. It is essential for patients to follow the treatment regimen to prevent vision deterioration.
Common side effects include a burning or stinging sensation in the eyes, dry eyes, headache, and fatigue. In rare cases, allergic reactions or breathing difficulties may occur.
This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.